Phase 3 Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Non-Infectious Anterior Segment Uveitis
The purpose of this study is to evaluate the safety and efficacy of iontophoresis treatment with dexamethasone phosphate ophthalmic solution in patients who have non-infectious anterior segment uveitis.
Iontophoresis is an investigational drug delivery system which was developed as a means to non-invasively deliver dexamethasone into the eye.
Phase 3 Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Non-Infectious Anterior Segment Uveitis
The purpose of this study is to evaluate the safety and efficacy of iontophoresis treatment with dexamethasone phosphate ophthalmic solution in patients who have non-infectious anterior segment uveitis.
Iontophoresis is an investigational drug delivery system which was developed as a means to non-invasively deliver dexamethasone into the eye.
This clinical study is for patients requiring Cataract Surgery. Participants will receive FDA-Approved premium multifocal lenses at a discount price.
Duration = 6 months
This study is available for patients requiring reading glasses. There will be similar studies available in the near future.
Duration = 3 years
This clinical study is designed to correct Nearsightedness through the use of foldable intraocular lenses.
Duration = 3 years
This study is for Cataract Surgery with specific monofocal lenses. We are researching the adjustments made after the implant.
Duration = 3 years
This clinical study evaluates seeing near and far (simultaneously), after receiving Dual Optic Cataract implants.
Duration = 3 years
The Pepose Vision Institute is currently enrolling for Clinical Studies. Please use our interactive study viewer above to access general information on current and ongoing Clinical Studies.
If you have questions regarding a specific study, or for general questions and inquires, please feel free to contact us.